Skip to content
Oncology Research Hub

Tennessee

Cancer clinical trials in Tennessee

451 cancer studies are recruiting participants at sites in 26 cities across Tennessee as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Tennessee city with a recruiting study

By research area: Breast Cancer (137), Lung Cancer (132), Lymphoma (91), Prostate Cancer (41), Melanoma (26), Pancreatic Cancer (24).

Nashville (344), Memphis (94), Knoxville (57), Germantown (30), Collierville (27), Chattanooga (26), Kingsport (7), Franklin (5), Mount Juliet (5), Johnson City (4), Shelbyville (4), Bartlett (3), Cleveland (3), Lebanon (3), Murfreesboro (3), Smyrna (3), Alcoa (2), Cookeville (2), Gallatin (2), Dickson (1), Hendersonville (1), Jackson (1), Nashvile (1), Nasville (1), Oak Ridge (1), Tennessee City (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Tennessee

Basic details from each study's public record (the 12 most recently updated of 451). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Memphis · Nashville
    Registry record
    NCT06324357 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Tennessee on ClinicalTrials.gov.

Lung cancer: recently updated in Tennessee

  1. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    Nashville
    Registry record
    NCT07277413 · updated
  2. A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Eikon Therapeutics
    Recruiting in
    Nashville
    Registry record
    NCT07365319 · updated
  3. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Knoxville
    Registry record
    NCT07513376 · updated
  4. A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Nashville
    Registry record
    NCT07730021 · updated
  5. A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Nashville
    Registry record
    NCT07903415 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Tennessee on ClinicalTrials.gov.

Prostate cancer: recently updated in Tennessee

  1. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Memphis · Nashville
    Registry record
    NCT05011383 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Tennessee on ClinicalTrials.gov.

Melanoma: recently updated in Tennessee

  1. Molecular Analysis of Childhood and Adolescent Melanocytic Lesions

    • Observational
    • Up to age 18
    • All sexes
    Sponsor
    St. Jude Children's Research Hospital
    Recruiting in
    Memphis
    Registry record
    NCT02775643 · updated
  2. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Nashville
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Tennessee on ClinicalTrials.gov.

Lymphoma: recently updated in Tennessee

  1. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Chattanooga · Nashville
    Registry record
    NCT06806033 · updated
  2. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Nashville
    Registry record
    NCT07221500 · updated
  3. Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Nashville
    Registry record
    NCT07520006 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Tennessee on ClinicalTrials.gov.

Ask about studies in Tennessee

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call